IL35 Level in Vitiligo
Not yet recruiting
- Conditions
- IL35, Vitiligo
- Interventions
- Diagnostic Test: IL 35 in tissue biopsy
- Registration Number
- NCT05980390
- Lead Sponsor
- Cairo University
- Brief Summary
The aim of this observational study is to evaluate the level of the IL-35 protein in tissue biopsy from patients with active \& stable vitiligo.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
- Patients with active and stable vitiligo
Read More
Exclusion Criteria
- Pregnant and lactating women.
- Patients with associated autoimmune or other dermatological diseases e.g., Alopecia areata and lupus erythematous.
- Patients already on both topical and systemic treatment at the time of recruitment.
- Patients on Immunosuppressive drugs.
- Other hypopigmented diseases such as pityriasis alba, tinea versicolor, lichen sclerosis, post inflammatory hypopigmentation and leprosy as excluded by lack of accentuation by wood's light examination.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Normal controls IL 35 in tissue biopsy - Stable vitiligo IL 35 in tissue biopsy - Active vitiligo IL 35 in tissue biopsy -
- Primary Outcome Measures
Name Time Method level of IL35 in tissue biopsy 3 months
- Secondary Outcome Measures
Name Time Method